Our data reveal the functional crosstalk between ERK‐mediated cell survival and caspase‐mediated cell death pathways and suggest that its dysregulation by a disease‐associated MEK1 mutation is at least partly involved in the pathophysiology of congenital RASopathies. The gene discussed is MAP2K1; the disease is RASopathy.